Professor of Hematology Erasmus MC, dept. of Hematology and President of EMN
EMN, Netherlands
Professor Pieter Sonneveld
Erasmus MC
Department of Hematology
PO Box 2040
Rotterdam
Netherlands
Cell: +31-6-11608230
p.sonneveld@erasmusmc.nl
Pieter Sonneveld received his medical degree from the Erasmus University in Rotterdam, The Netherlands in 1977. In 1980 he completed a Ph.D. thesis on the pharmacology of Adriamycin at the University of Leiden (DW van Bekkum & HM Pinedo, promotores), received a Fogarty Fellowship, worked at the National Cancer Institute, Bethesda, USA.
Dr. Sonneveld is Professor of Hematology at the Erasmus University Rotterdam and Chair of the Erasmus MC Cancer Institute in Rotterdam. From 2011 to 2017 he was the head of the department of Hematology. His research focus is on clinical and translational aspects of multiple myeloma. His myeloma research group in Erasmus MC has been very active in molecular diagnostics and micro environment of myelome.
He is chairman of the HOVON Myeloma Working Group and coordinates HOVON and EMN clinical trials. He helped to found the European Myeloma Network and has been chairman since. Within EMN, he coordinates a cooperative network for independent clinical trials in Europe. EMN currently runs international trials and registration trials for novel treatments.
He has been Board member and President (2017-2019) of the EHA, and chair of its SWG. He has chaired the Scientific Program Committee of the 19th EHA congress in Milan 2014 and of the EMN meetings in 2018 and 2021.
He serves on the Scientific Advisory Boards of the IMF and MMRF and is a member of the International MWG. He has been a member of many Editorial Boards and has authored more than 500 peer reviewed scientific publications and several chapters. He has received grants for his research.
In 2015 he was awarded the international Robert Kyle Award in MM and in 2019 received the Hubertus Wald Award for Cancer Research from Germany.